Pharma Manufacturing
India’s PLI scheme is rebuilding API manufacturing with local capacity, tech upgrades, and reduced import dependence.
Vaibhavi M. | Dec 11, 2025
Building KSM Manufacturing Clusters: Opportunities For SMEs In The Pharmaceutical Industry
Vaibhavi M. | Dec 06, 2025
PVC-Free, Recyclable, and Compostable Blister Packs: The Future of Green Pharma Packaging
Ravindra Warang | Jun 23, 2025
Smart Blister Packaging: How IoT and AI Are Transforming Patient Adherence
Ravindra Warang | Jun 21, 2025
Other trending pieces on pharma manufacturing you may like to read
Manufacturing mRNA Therapeutics: An Overview
Explore how mRNA therapeutics are manufactured, from DNA templates to LNP formulation, with key challenges, regulations, and future trends.
by Mrudula Kulkarni
Vaccine Contract Manufacturing Market in 2026: Trends, Growth Drivers, and Strategic Outlook
Vaccine contract manufacturing in 2026 shifts toward digitalization, regionalization, and strategic CDMO partnerships powering global immunization
by Mrudula Kulkarni
Water Stewardship in High-risk Zones: Pharma’s Call to Action in 2026
Why water stewardship is critical for pharma manufacturing in 2026 and how it impacts global health, supply chains, and community resilience.
by Thaddeus Anim-Somuah
From Generics Giant To Biologics Powerhouse: India’s Next Big Pharma Revolution
India is transitioning from generics dominance to a global biologics and biosimilars leader, shaping the future of advanced therapies.
by Simantini Singh Deo
API Manufacturing Automation: How Robotics Are Reducing Risks In Hazardous Steps?
Automation and robotics are transforming API manufacturing with better safety, precision, and efficiency across hazardous steps.
by Simantini Singh Deo
